Print version of this report

TGA Action ID	RC-2026-RN-00749-1
Type of Product	Medicine
Product Name/Description	Swisse Nutra+ Andro Max 30 tabs and Swisse Ultiboost Immune Action 60 tabs Batch/Lot Number(s): All batches within expiry
ARTG Number	326345, 330145
Action Type	Recall
Action Level	Consumer
Hazard Classification	Class I
Reason for the Action	Since 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis. However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines. Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no longer available for use in new listed (low risk) medicines for supply in Australia.
Instructions for Customers/Users	Distributors and retailers: • Inspect their stock immediately and quarantine affected stock on hand to prevent further use. • Return the completed Customer Response Form even if they do not have any affected stock. • Notify any downstream commercial customers to whom they have supplied the affected stock and instruct them to immediate cease supply and follow the recall instructions. Consumers: • Consumers are advised that if they have the above products, do not use them. • Consumers can contact Swisse Wellness on 1800 794 773 or email recall@swisse.com.au to arrange the return and refund of the product. Swisse Wellness will provide return instructions and will cover the cost of returning the product. • If someone is suspected of having anaphylaxis, call for emergency medical help immediately by dialling ‘000’.
Action Commencement Date	16/10/2026
Responsible Entity	Swisse Wellness Pty Ltd
Contact Information	1800 794 773 or recall@swisse.com.au - Swisse Wellness